| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | BGC 20-1531 hydrochloride |
|---|
| Description | High affinity and selective EP4 antagonist (Ki = 3 nM). Exhibits >2500-fold selectivity for EP4 over EP2 and EP3. Also selective over a range of other prostanoid receptors, ion channels, transporters and enzymes. Inhibits PGE2-induced vasodilation of middle cerebral and meningeal arteries in vitro, and carotid blood flow in vivo. Orally bioavailable. Purity 98%. MW (observed): 529 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-[[4-(5-Methoxy-2-pyridinyl)phenoxy]methyl]-5-methyl-N-[(2-methylphenyl)sulfonyl]-2-furancarboxamide hydrochloride. PGN 1531 |
|---|
| Gene, Accession, CAS # | CAS: 1962928-26-2 |
|---|
| Catalog # | 5327/10 |
|---|
| Price | |
|---|
| Order / More Info | BGC 20-1531 hydrochloride from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 30397349 |
|---|
| 產(chǎn)品資料 |
|
|